QTR Family Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
QTR Family Wealth's BIIB Position: Q1 2026 in Review
QTR Family Wealth increased its Biogen (BIIB) stake by 7.5% in Q1 2026, buying an estimated $25.4K and bringing the position to 1,990 shares worth $356K. The position accounts for 0.15% of the portfolio, ranked #162.
QTR Family Wealth first reported a position in BIIB in Q3 2025 and has held it in 3 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- QTR Family Wealth held 1,990 shares of Biogen worth $356K as of Q1 2026.
- QTR Family Wealth bought 138 Biogen shares in Q1 2026, an estimated $25.4K.
- Biogen made up 0.15% of QTR Family Wealth's portfolio in Q1 2026, its #162 holding.
- QTR Family Wealth first reported a position in Biogen in Q3 2025 and has held it in 3 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on QTR Family Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.